Search
for
Sort by
Research 61–90 of 1000+
- Comparative study of efficacy of topical mometasone with calcipotriol versus mometasone alone in the treatment of alopecia areata
- Exploring the efficacy of baricitinib in treating alopecia areata after failed Janus kinase inhibitor therapy
- Evaluation of association of vitamin D in alopecia areata: A case–control study of 100 patients in a tertiary rural hospital of Southern India
- Treatment of alopecia areata with the janus kinase inhibitor upadacitinib: A retrospective cohort study
- Wharton’s jelly-derived mesenchymal stem cells in the treatment of four patients with alopecia areata
- Dietary Habits in Japanese Patients with Alopecia Areata
- Study on Serum Vitamin D in Alopecia Areata Patients
- An Excellent Response to Tofacitinib in a Pediatric Alopecia Patient: A Case Report and Review.
- 544 Alopecia areata lesions show significant changes in immune and keratin biomarkers that correlate with clinical improvement with oral Janus kinase inhibitors PF-06651600 (JAK3) and PF-06700841 (TYK2/JAK1)
- European expert consensus statement on the systemic treatment of alopecia areata
- Real-world assessment of ritlecitinib in patients with severe alopecia areata: a 24-week multicentre retrospective study
- 67 Patterns of clinical response in patients with alopecia areata (AA) treated with ritlecitinib in the ALLEGRO phase 2b/3 and ongoing, phase 3, ALLEGRO-LT studies
- LB785 Efficacy and safety of baricitinib in adults with Alopecia Areata: Phase 3 results from a randomized controlled trial (BRAVE-AA1)
- SALT score distribution with ritlecitinib treatment up to 24 months in alopecia areata
- Serum interleukin-37 and its gene polymorphism (rs3811047) in Egyptian patients with alopecia areata
- The relative efficacy of monotherapy with Janus kinase inhibitors, dupilumab and apremilast in adults with alopecia areata: Network meta‐analyses of clinical trials
- COVID-19 vaccination related exacerbations of hair loss in patients with moderate-to-severe alopecia areata on systemic therapy
- Not just thinning: A case of alopecia universalis after mild COVID-19
- The effect of latanoprost 0.005% solution in the management of scalp alopecia areata, a randomized double‐blind placebo‐controlled trial
- Time to loss of response for dupilumab in ophiasis-pattern alopecia areata
- Correlation between serum granulysin level and clinical activity in patients with alopecia areata before and after tofacitinib therapy
- A clinical study on alopecia areata
- Progressive alopecia areata during TNF-α inhibition with intralesional corticosteroid failure and subsequent improvement following JAK1 inhibition
- Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study
- Development of the AAcQLI : A New Instrument for Assessing Quality of Life in Children With Alopecia Areata
- Long-term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-year Results from the ALLEGRO-LT Phase 3, Open-label Study
- Dermoscopic Analysis of Patients with and without Poor Prognostic Indicators in Alopecia Areata – A Comparative Study
- Alopecia Areata in Skin of Color: Trichoscopic Analysis in Black/African American Patients
- COMPARISON OF EFFICACY OF BARICITINIB VERSUS METHOTREXATE THERAPY IN THE TREATMENT OF SEVERE ALOPECIA AREATA
- Systemic Tofacitinib in Alopecia Areata: A Single Center Retrospective Descriptive Cohort Study